Search Results - "Dechavanne, Marc"

Refine Results
  1. 1

    Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol by Girard, P, Nony, P, Erhardtsen, E, Delair, S, Ffrench, P, Dechavanne, M, Boissel, J P

    Published in Thrombosis and haemostasis (01-07-1998)
    “…This study establishes a population PK model for FVII clotting activity (FVII:C) after injection of recombinant activated factor VII (rFVIIa) to healthy…”
    Get more information
    Journal Article
  2. 2

    Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: A study of 157 cases by TROUILLAS, Paul, DEREX, Laurent, PHILIPPEAU, Fréderic, NIGHOGHOSSIAN, Norbert, HONNORAT, Jerome, HANSS, Micel, FFRENCH, Patrick, ADELEINE, Patrice, DECHAVANNE, Marc

    Published in Stroke (1970) (01-06-2004)
    “…Little is known about the coagulation factors as predictors of cerebral bleeding in rt-PA thrombolysis. The aim of this study was to determine what early…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Inherited bleeding disorder due to familial type 2 platelet cyclo-oxygenase deficiency by Dargaud, Yesim, Bordet, Jean C., Trzeciak, Marie C., Mazet, Martine, Dechavanne, Marc, Negrier, Claude

    Published in Thrombosis research (2005)
    “…Inherited platelet cyclo-oxygenase (COX) deficiency is a rare bleeding disorder. We report here the first case of familial type 2 platelet COX deficiency…”
    Get full text
    Journal Article
  6. 6

    Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts by Maillard, C, Berruyer, M, Serre, C M, Dechavanne, M, Delmas, P D

    Published in Endocrinology (Philadelphia) (01-03-1992)
    “…Protein-S is a vitamin K (Vit K)-dependent protein synthesized by hepatocytes, megakaryocytes, and endothelial cells and plays an important role in the…”
    Get more information
    Journal Article
  7. 7

    Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients by Bissuel, F, Berruyer, M, Causse, X, Dechavanne, M, Trepo, C

    “…A plasma free protein S deficiency was detected in 41 of 63 patients infected with the human immunodeficiency virus type I (HIV-1). This study consisted in a…”
    Get more information
    Journal Article
  8. 8

    A splicing donor site point mutation in intron 6 of the plasmin inhibitor (α2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency by Hanss, Michel ML, Farcis, Mathilde, Ffrench, Patrick O, de Mazancourt, Philippe, Dechavanne, Marc

    Published in Blood coagulation & fibrinolysis (01-01-2003)
    “…A new case of familial plasmin inhibitor (α2 antiplasmin) deficiency is reported. The bleeding symptoms are moderate, happening after surgery or trauma or…”
    Get full text
    Journal Article
  9. 9

    Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke. Correlations of outcome with clinical and radiological data by Trouillas, P, Nighoghossian, N, Getenet, J C, Riche, G, Neuschwander, P, Froment, J C, Turjman, F, Jin, J X, Malicier, D, Fournier, G, Gabry, A L, Ledoux, X, Derex, L, Berthezène, Y, Adeleine, P, Xie, J, Ffrench, P, Dechavanne, M

    Published in Stroke (1970) (01-05-1996)
    “…Pilot studies using early thrombolytic therapy in stroke have suggested that recombinant tissue plasminogen activator (rTPA) might be effective. While large,…”
    Get full text
    Journal Article
  10. 10

    Illegitimate transcription: its use for studying genetic abnormalities in lymphoblastoid cells from patients with Glanzmann thrombasthenia by Negrier, Claude, Vinciguerra, Christine, Attali, Olivier, Grenier, Christine, Larcher, Marie Estelle, Dechavanne, Marc

    Published in British journal of haematology (01-01-1998)
    “…Glanzmann thrombasthenia is the most common inherited disorder of platelets that may induce severe bleeding complications. Molecular biology techniques have…”
    Get full text
    Journal Article
  11. 11

    In vitro tests for assessing heparin-induced thrombocytopenia in patients after elective hip replacement. A medico-economical evaluation by Sobas, Frédéric, Colin, Cyrille, Ffrench, Patrick, Trzeciak, Marie Christine, Dechavanne, Marc, Négrier, Claude

    “…Considering the previously published incidences of heparin-induced thrombocytopenia (HIT) in patients receiving a thromboprophylactic therapy, the role of the…”
    Get more information
    Journal Article
  12. 12

    Efficacy and safety of continuous infusion of Mononine® during five surgical procedures in three hemophilic patients by Ménart, Christophe, Petit, Pierre Yves, Attali, Olivier, Massignon, Denis, Dechavanne, Marc, Négrier, Claude

    Published in American journal of hematology (01-06-1998)
    “…We report here five surgeries successfully performed with a continuous infusion of Mononine® (Armour Pharmaceutical Company, Kankakee, IL) in three hemophilic…”
    Get full text
    Journal Article
  13. 13

    Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane by Maillard, C, Berruyer, M, Serre, C M, Amiral, J, Dechavanne, M, Delmas, P D

    Published in Endocrinology (Philadelphia) (01-08-1993)
    “…We have previously shown that protein S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Because protein S…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Combined factor IX and protein C deficiency in a child: thrombogenic effects of two factor IX concentrates by Negrier, C, Vial, J, Vinciguerra, C, Berruyer, M, Dechavanne, M

    Published in American journal of hematology (01-02-1995)
    “…We have recently described an unusual situation which involved a combination of a factor IX and a protein C deficiency in a young child who presented,…”
    Get more information
    Journal Article
  16. 16

    Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease by Gaucher, C, Hanss, M, Dechavanne, M, Mazurier, C

    Published in British journal of haematology (01-01-1993)
    “…Type IIA is a variant form of von Willebrand disease (vWD) characterized by the absence of von Willebrand factor (vWF) high molecular weight multimers in…”
    Get more information
    Journal Article
  17. 17

    Results of splenectomy for idiopathic thrombocytopenic purpura. Review of 72 cases by Naouri, A, Feghali, B, Chabal, J, Boulez, J, Dechavanne, M, Viala, J J, Tissot, E

    Published in Acta haematologica (1993)
    “…Seventy-two patients underwent splenectomy for idiopathic thrombocytopenic purpura between 1979 and 1990. Mean age at splenectomy was 36.4 years (range 11-73)…”
    Get more information
    Journal Article
  18. 18

    Osteonectin is an α‐granule component involved with thrombospondin in platelet aggregation by Clezardin, Philippe, Malaval, Luc, Trzeciak, Marie‐Christine, Guichard, Josette, Lecompte, Thomas, Morel, Marie‐Christine, Dechavanne, Marc, Breton‐Gorius, Janine, Delmas, Pierre D., Kaplan, Cécile

    Published in Journal of bone and mineral research (01-10-1991)
    “…We previously showed that thrombospondin, a major α‐granule glycoprotein of human platelets, forms a specific complex with osteonectin, a phosphoglycoprotein…”
    Get full text
    Journal Article
  19. 19

    Expression of adhesion molecules in endothelial cells during allogeneic bone marrow transplantation by Shen, N, Ffrench, P, Guyotat, D, Ffrench, M, Fiere, D, Bryon, P A, Dechavanne, M

    Published in European journal of haematology (01-05-1994)
    “…Endothelial cell activation during allogeneic bone marrow transplantation, mainly in acute graft-versus-host disease (aGvHD) was studied in 23 recipients and 5…”
    Get more information
    Journal Article
  20. 20

    Priming effect of adrenic acid (22:4(n-6)) on tissue factor activity expressed by thrombin-stimulated endothelial cells by Tardy, B, Bordet, J C, Berruyer, M, Ffrench, P, Dechavanne, M

    Published in Atherosclerosis (01-07-1992)
    “…Tissue factor (TF) which initiates clotting process can be expressed by stimulated endothelial cells (EC). TF is an apolipoprotein requiring an association…”
    Get more information
    Journal Article